Marrone Bio Innovations Posts Wider Quarterly Loss

Marrone Bio Innovations, Inc., a provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, posted a wider third-quarter net loss as expenses rose; however, revenue rose 16% in the period.

The net loss was $8.5 million in the quarter, compared with a loss of $7.2 million a year earlier.

Financial Highlights

  • GAAP revenues grew 31% to $14.8 million for the first nine months of 2017, compared to $11.4 million in the same year-ago period. GAAP revenues increased 16% to $4.2 million in the third quarter of 2017, compared to $3.6 million in the third quarter of 2016.
  • Product shipments1 grew 36% to $15.2 million for the first nine months of 2017, compared to $11.2 million in the same year-ago period. Product shipments were $3.1 million in the third quarter of 2017, compared to $3.1 million in the third quarter of 2017.
  • Gross margin increased to 41.2% for the first nine months of 2017, compared to 30.6% in the same year-ago period. Gross margin increased significantly to 40.9% in the third quarter of 2017, compared to 31.4% in the third quarter of 2016.
  • In October 2017, the Company entered into an unsecured promissory note with an investor, enabling the funding of certain tranches at the lender’s sole discretion. To date, the Company has received $2.0 million in funding under the note.

“We experienced several noteworthy catalysts in the third quarter of 2017, such as completion of our Grandevo WDG granulation line, as well as receiving EPA registration for MBI-110, which is the seventh product we’ve commercialized in 11 years,” said Dr. Pam Marrone, CEO of MBI. “Despite these major events, unfavorable weather conditions reduced the number of expected sprays in several of our key markets. Historically, the third quarter produces the lowest sales of the year and is the most unpredictable, evidenced by hurricanes Irma and Maria which significantly impacted our sales in Florida and Puerto Rico. Fortunately, our portfolio approach to product development and marketing diversifies our revenue base and reduces the impact of any one variable on the success of the company as a whole, and allowed us to achieve above industry-average growth for the first nine months of 2017.

“We remain positive on the long-term outlook of our business and have made significant progress in penetrating the United States market and abroad. To that end, we have greatly expanded our reach in international markets through select partnerships with regionally significant firms such as ÉLÉPHANT VERT in North Africa, Kenya Biologics in Kenya and Tanzania. We have taken significant steps to increase product awareness in the substantial Central and South American market, such as sponsoring grower education events in Honduras and Chile, as well as successfully advancing field trials in Brazil, which have shown tremendous results to-date.

“We’ve also made an immense amount of progress on the R&D front and are near completing the development of our first generation bio-herbicide, MBI-014, which remains on track for EPA submission in the near-term. MBI-014 will address one of the largest needs of organic farming—controlling weeds—and we believe it will be the first new mode of action herbicide in 25 years. Also in the third quarter, on October 27, 2017, we received EPA registration for MBI-110—which we branded ‘Stargus™’, for specialty crops and ‘Amplitude™’ for row crops. To our knowledge, no other agricultural company has successfully commercialized 7 new agricultural products from 6 active ingredients in such a short amount of time.”

Dr. Marrone concluded: “These R&D advancements, paired with the considerable progress in advancing distribution and product awareness, are translating into greater market opportunities and enhanced potential to create shareholder value.”

Recent Operational Highlights

  • Realized exceptional results from field trials in Brazil for Regalia®, Grandevo®, Majestene®, and Venerate®. MBI now anticipates a clear path to completion of the registration process in the country, paving the way to commercial sales in the large Brazilian crop protection market.
  • Received EPA registration for MBI-110, branded “Stargus™” for specialty crops and “Amplitude™” for row crops. MBI plans to launch Stargus™ in the United States market in 2017.
  • Completed the development of MBI-014 (formerly 010), an organic bio-herbicide that is set for an EPA submission in the near-term.
  • Albaugh, a major row crop seed treatment provider, had a successful first season with the BioST seed treatment containing an MBI microorganism. Preliminary results are positive and point to substantial yield increases over the standards.
  • Developed a strategy and focus to address grower demand of MBI products within the cannabis market through the creation of smaller pack sizes, hiring a cannabis segment sales specialist and utilizing Amazon as a direct-to-consumer sales channel.
  • As part of MBI’s collaboration with Evogene, transgenic plants carrying MBI’s insecticidal genes were developed and one candidate showed promising results (100% kill) against cabbage looper. Additional tests are in progress.
  • Joined a pilot project with AgShift, a Santa Clara-based agriculture technology startup, to assess the impact of the use of biological pesticides on the quality of fresh produce.
  • Signed new distribution agreements in Africa with regionally significant firms such as ÉLÉPHANT VERT in North Africa and Kenya Biologics in Kenya and Tanzania.
  • Finalized a distribution agreement with a large water treatment company for Zequanox.
  • Currently in discussions with several food companies about how to best transition growers to organic and help their grower suppliers with specific pest and disease problems.
  • Sponsored educational symposia for growers in Honduras and Chile with prominent local organizations to spread awareness of modern agricultural production technologies, including the use of biopesticides and stimulants in specialty crops.
  • Completed construction of the Grandevo WDG granulation line at MBI’s Marrone Michigan Manufacturing facility. This is currently producing a second-generation formulation to allow MBI to meet anticipated demand for this innovative new formulation.
  • Discovered new methods to increase the potency of Majestene and Grandevo, driving notably higher gross margins and increasing the effective capacity of the Marrone Michigan Manufacturing facility.
Topics: ,

Biopesticides

Biopesticides

Marrone Bio Innovations Announces Comprehensive Financing and Debt Restructuring Transaction

Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and

Biopesticides

BioProtection Association Expands Global Footprint, Elects New President

BioProtection Global (BPG), the global association of regional trade organizations representing the biological products industry, has announced the incorporation of

Agrichemicals

Slideshow: AgriBusiness Global Hosts Trade Summit Southeast Asia

AgriBusiness Global hosted its Trade Summit Southeast Asia from Dec. 5-6 in Jakarta, Indonesia at the J S Luwansa Hotel.

Biopesticides

Marrone Bio Innovations Introduces Amplitude Biofungicide for White Mold Control

Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental

Biopesticides

Flamingo Commits $2.4 Million Investment to African Biopesticide Subsidiary

Flamingo Horticulture Investments (FHI Ltd), a Sun Capital Europe portfolio organization, has announced it will make a further investment of

Biopesticides

Seawin Biotech Group Launches U.S. Business Division

Qingdao Seawin Biotech Group has announced the launch of the U.S. business division. As China’s largest manufacturer of fertilizers made

Americas

Valent USA Launches Aveo EZ Nematicide

Aveo EZ is a biological seed protectant that colonizes the roots of the soybean plant to reduce nematode reproduction.

Biopesticides

Marrone Bio Innovations Receives EPA Approval for Novel Biofungicide

The product, which is the sixth one to be commercialized by MBI in 11 years, is based on a new strain of Bacillus amyloliquefaciens discovered by MBI.

Biopesticides

Stockton, Lidorr Build Biological Manufacturing Unit

This manufacturing unit was designed to provide STK with the necessary capacity to advance its growing pipeline of biopesticides, hybrids and other biocontrol formulations.

Africa/Middle East

Marrone Bio Innovations Signs Exclusive Distribution Agreement with Kenya Biologics Ltd. for Kenya and Tanzania

The agreement Includes Reysana™ (Regalia®), Grandevo®, Venerate® and Majestene®.

Biopesticides

Valent U.S.A. Launches Sustainable Solutions Business Unit

Valent U.S.A. LLC has launched its Sustainable Solutions Business Unit, a new division within the company that is completely dedicated

Africa/Middle East

Marrone Bio Innovations Signs Distribution Agreement in North Africa

ÉLÉPHANT VERT, which has 300 employees in five countries in Africa and Europe and develops and markets organic amendments, biofertilizers, biostimulants and 100% natural biopesticides made in four production units, will develop and market two of MBI's products in Morocco, Tunisia and Algeria:

Biopesticides

Bayer, Ginkgo Bioworks Join Forces for Sustainable Agriculture

Bayer and Ginkgo Bioworks will create a new company focused on the plant microbiome. Improving the microbes’ ability to make

Africa/Middle East

Africa Faces Annual $2bn-plus Maize Deficit if Fall Armyworm Poorly Managed

The Centre for Agriculture and Biosciences International (CABI) has confirmed that Fall Armyworm (FAW) has been reported in 28 African

Biopesticides

AgShift Launches Pilot Project with Marrone Bio Innovations to Assess Biopesticides

Marrone Bio Innovations, a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and

Americas

AgBiome’s Howler Fungicide Receives EPA Approval

The first product to be marketed by AgBiome Innovations and developed by AgBiome Inc., is a biological fungicide that is highly effective against fungal diseases common to high-value crops.

Asia

Stockton Signs Distribution Deal with Syngenta Australia

The agreement grants Syngenta the exclusive right to distribute STK’s Timorex Gold biofungicide for application in edible crops in Australia and New Zealand.

Americas

Vive Crop Protection in Partnership with SDTC

Vive Crop Protection is pleased to announce a new partnership with four biopesticide manufacturers to develop new and improved biopesticides, supported by Sustainable Development Technology Canada (SDTC).

Americas

Cutting Edge Conferences: Meister Media to Host Precision Agriculture and Biocontrols Events

Biological control products and precision agriculture are among the fastest growing and most promising areas of growth for the crop

Latest News

Africa/Middle East

Kenya Dairy Industry Sheds Light on Market Challenges, Opportunities

In December, I had the privilege to serve as a volunteer consultant with the USAID Farmer-to-Farmer (F2F) program in Kenya.

Agrichemicals

Opinion: Why the Crop Protection Industry Needs Strategic Vision

The crop protection industry faces a dilemma. In the uncertain and globally competitive world of crop protection, focus has primarily

NPK

Sustainability at The Mosaic Company: Former CEO Shares Insight into How They Did It

Leading an organization today requires navigating the pushes and pulls of multiple stakeholders: generating shareholder returns, delivering value to customers,

Africa/Middle East

Eastern African Nations Move to Harmonize Fertilizer Regulations

Eastern Africa countries are working to harmonize the region’s fertilizer market, a move that could improve not only demand for

Agrichemicals

CAC Crop Protection Show Continues to Expand

China’s agrichemical industry continues to deal with strict environmental regulations, which have impacted sourcing around the world. CAC 2018 gives